The State Administration for Market Regulation has approved the establishment of a joint venture between Hangyang Group Co., Ltd. and Shandong Haili Chemical Co., Ltd. This approval was part of a list of unconditionally approved business concentration cases released on July 13-19, 2026. The list also included other cases such as Shanghai Pharmaceuticals Health Cloud Commerce Co., Ltd.'s acquisition of equity in multiple companies. AI
RANK_REASON Regulatory approval of a joint venture between two companies. [lever_c_demoted from significant: ic=1 ai=0.1]
- Hangyang Group Co., Ltd.
- Shandong Haili Chemical Co., Ltd.
- Shanghai Pharmaceuticals Health Cloud Commerce Co., Ltd.
- State Administration for Market Regulation
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
